These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7758454)

  • 1. Functions of [His321]gelsolin isolated from a flat revertant of ras-transformed cells.
    Fujita H; Laham LE; Janmey PA; Kwiatkowski DJ; Stossel TP; Banno Y; Nozawa Y; Müllauer L; Ishizaki A; Kuzumaki N
    Eur J Biochem; 1995 May; 229(3):615-20. PubMed ID: 7758454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-inhibitory functions of a mutated gelsolin (His321) in NIH/3T3 mouse fibroblasts.
    Ishizaki A; Fujita H; Kuzumaki N
    Exp Cell Res; 1995 Apr; 217(2):448-52. PubMed ID: 7698245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated gelsolin and alpha-actin expression in a flat revertant R1 of Ha-ras oncogene-transformed NIH/3T3 cells.
    Müllauer L; Fujita H; Suzuki H; Katabami M; Hitomi Y; Ogiso Y; Kuzumaki N
    Biochem Biophys Res Commun; 1990 Sep; 171(2):852-9. PubMed ID: 2169737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinase.
    Heldman AW; Kandzari DE; Tucker RW; Crawford LE; Fearon ER; Koblan KS; Goldschmidt-Clermont PJ
    Circ Res; 1996 Feb; 78(2):312-21. PubMed ID: 8575075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogene.
    Fujita H; Suzuki H; Kuzumaki N; Müllauer L; Ogiso Y; Oda A; Ebisawa K; Sakurai T; Nonomura Y; Kijimoto-Ochiai S
    Exp Cell Res; 1990 Jan; 186(1):115-21. PubMed ID: 2153549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress of research on tumor suppressor genes].
    Kuzumaki N
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):133-7. PubMed ID: 8641669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
    Müllauer L; Fujita H; Ishizaki A; Kuzumaki N
    Oncogene; 1993 Sep; 8(9):2531-6. PubMed ID: 8395682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
    Fujita H; Okada F; Hamada J; Hosokawa M; Moriuchi T; Koya RC; Kuzumaki N
    Int J Cancer; 2001 Sep; 93(6):773-80. PubMed ID: 11519036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain structure in actin-binding proteins: expression and functional characterization of truncated severin.
    Eichinger L; Noegel AA; Schleicher M
    J Cell Biol; 1991 Feb; 112(4):665-76. PubMed ID: 1847147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The actin side-binding domain of gelsolin also caps actin filaments. Implications for actin filament severing.
    Sun HQ; Wooten DC; Janmey PA; Yin HL
    J Biol Chem; 1994 Apr; 269(13):9473-9. PubMed ID: 8144531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
    Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
    Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.
    Fujita H; Allen PG; Janmey PA; Azuma T; Kwiatkowski DJ; Stossel TP; Furu-uchi K; Kuzumaki N
    Eur J Biochem; 1997 Sep; 248(3):834-9. PubMed ID: 9342236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility.
    Chen P; Murphy-Ullrich JE; Wells A
    J Cell Biol; 1996 Aug; 134(3):689-98. PubMed ID: 8707848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).
    Tikoo A; Varga M; Ramesh V; Gusella J; Maruta H
    J Biol Chem; 1994 Sep; 269(38):23387-90. PubMed ID: 8089100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CapG gain-of-function mutant reveals critical structural and functional determinants for actin filament severing.
    Zhang Y; Vorobiev SM; Gibson BG; Hao B; Sidhu GS; Mishra VS; Yarmola EG; Bubb MR; Almo SC; Southwick FS
    EMBO J; 2006 Oct; 25(19):4458-67. PubMed ID: 16977317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelsolin modulates phospholipase C activity in vivo through phospholipid binding.
    Sun Hq; Lin Km; Yin HL
    J Cell Biol; 1997 Aug; 138(4):811-20. PubMed ID: 9265648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel Ras-binding protein Ce-FLI-1 comprising leucine-rich repeats and gelsolin-like domains.
    Goshima M; Kariya K; Yamawaki-Kataoka Y; Okada T; Shibatohge M; Shima F; Fujimoto E; Kataoka T
    Biochem Biophys Res Commun; 1999 Apr; 257(1):111-6. PubMed ID: 10092519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis.
    Way M; Gooch J; Pope B; Weeds AG
    J Cell Biol; 1989 Aug; 109(2):593-605. PubMed ID: 2547804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.